From single cell experiments to personalized medicine

Identifying the most effective substances by combinatorial drug screening requires a system that allows quick testing of as many combinations of drug candidates as possible. Since the substances are usually very expensive and rare, as little material as possible should be used for testing. All these attributes are perfectly fulfilled with ARRALYZE. The efficiency and quality of the ARRALYZE workstation for drug development also makes it a very promising approach for personalized medicine.

Cell Line Development (CLD) is a common procedure in many laboratories, to e.g. produce monoclonal antibodies and other pharmaceuticals. Cell line development requires months and thousands of individual tests. One major drawback of most current techniques is the inability to ensure monoclonality of the cells at the beginning of the development.

Please follow the link to learn more about how ARRALYZE enables you to ensure monoclonality in your CLD and reduce development risks.

Single cells behave differently to cell clusters and larger cell assemblies such as micro-tissue. It is of tremendous value for modern drug development and the targeted treatment of serious diseases to understand these differences on all levels. With the ARRALYZE glass arrays you have the unique opportunity to easily individualize the design of your array and to study individual cells and cell clusters up to the micro-tissue level on a single array.